Healthcare provider profile · identity verified

Nirav P Chudgar, MD

Internal Medicine · CALUMET CITY, IL · NPI 1780763805

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	630	195
Amlodipine Besylate	Amlodipine Besylate	540	166
Losartan Potassium	Losartan Potassium	329	97
Metformin Hcl	Metformin Hcl	307	92
Metoprolol Succinate	Metoprolol Succinate	271	81
Furosemide	Furosemide	223	81
Hydrochlorothiazide	Hydrochlorothiazide	215	72
Gabapentin	Gabapentin	209	79
Levothyroxine Sodium	Levothyroxine Sodium	209	58
Pantoprazole Sodium	Pantoprazole Sodium	206	85
Tamsulosin Hcl	Tamsulosin Hcl	177	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	164	31
Lisinopril	Lisinopril	160	47
Simvastatin	Simvastatin	154	42
Albuterol Sulfate Hfa	Albuterol Sulfate	142	57
Tizanidine Hcl	Tizanidine Hcl	140	51
Metoprolol Tartrate	Metoprolol Tartrate	138	38
Potassium Chloride	Potassium Chloride	129	46
Rosuvastatin Calcium	Rosuvastatin Calcium	114	38
Tramadol Hcl	Tramadol Hcl	114	29
Warfarin Sodium	Warfarin Sodium	113	11
Ozempic	Semaglutide	109	23
Glimepiride	Glimepiride	105	30
Eliquis	Apixaban	103	34
Finasteride	Finasteride	102	31
Ibuprofen	Ibuprofen	101	29
Omeprazole	Omeprazole	95	32
Fluticasone Propionate	Fluticasone Propionate	93	36
Hydralazine Hcl	Hydralazine Hcl	83	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	20
Montelukast Sodium	Montelukast Sodium	80	23
Prednisone	Prednisone	80	26
Carvedilol	Carvedilol	79	25
Alprazolam	Alprazolam	73	21
Triamcinolone Acetonide	Triamcinolone Acetonide	72	38
Trazodone Hcl	Trazodone Hcl	71	23
Azithromycin	Azithromycin	69	51
Ciprofloxacin Hcl	Ciprofloxacin Hcl	67	52
Nifedipine Er	Nifedipine	66	20
Duloxetine Hcl	Duloxetine Hcl	65	21
Meloxicam	Meloxicam	65	22
Allopurinol	Allopurinol	62	22
Clopidogrel	Clopidogrel Bisulfate	56	18
Olmesartan Medoxomil	Olmesartan Medoxomil	56	15
Linzess	Linaclotide	55	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	15
Diclofenac Sodium	Diclofenac Sodium	52	26
Escitalopram Oxalate	Escitalopram Oxalate	51	19
Meclizine Hcl	Meclizine Hcl	51	19
Cephalexin	Cephalexin	50	39
Jardiance	Empagliflozin	49	16
Alendronate Sodium	Alendronate Sodium	48	15
Famotidine	Famotidine	47	14
Mounjaro	Tirzepatide	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	12
Celecoxib	Celecoxib	45	11
Clonidine Hcl	Clonidine Hcl	44	12
Januvia	Sitagliptin Phosphate	43	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	42	16
Pravastatin Sodium	Pravastatin Sodium	42	15
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Metformin Hcl Er	Metformin Hcl	39	13
Pregabalin	Pregabalin	39	15
Vitamin D2	Ergocalciferol (Vitamin D2)	39	12
Acetaminophen-Codeine	Acetaminophen With Codeine	38	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	15
Clonazepam	Clonazepam	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Glipizide	Glipizide	34	13
Glipizide Er	Glipizide	33	suppressed
Nystatin	Nystatin	32	17
Valacyclovir	Valacyclovir Hcl	32	15
Benazepril Hcl	Benazepril Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Naproxen	Naproxen	30	12
Ondansetron Odt	Ondansetron	30	17
Entresto	Sacubitril/Valsartan	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Valsartan	Valsartan	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Nitroglycerin	Nitroglycerin	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	12
Atenolol	Atenolol	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	20
Levemir Flexpen	Insulin Detemir	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Lidocaine	Lidocaine	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Fluconazole	Fluconazole	18	13
Humalog	Insulin Lispro	18	suppressed
Tacrolimus	Tacrolimus	18	suppressed
Baclofen	Baclofen	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Emgality Pen	Galcanezumab-Gnlm	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	15	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Methylprednisolone	Methylprednisolone	14	12
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Temazepam	Temazepam	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Acarbose	Acarbose	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Colchicine	Colchicine	11	suppressed
Easy Comfort Pen Needles	Pen Needle, Diabetic	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Synthroid	Levothyroxine Sodium	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error